Delayed antibiotic prescribing for respiratory tract infections: protocol of an individual patient data meta-analysis.
Anti-Bacterial Agents
/ administration & dosage
Cost-Benefit Analysis
Drug Administration Schedule
Drug Prescriptions
Humans
Meta-Analysis as Topic
Observational Studies as Topic
Patient Satisfaction
Quality-Adjusted Life Years
Randomized Controlled Trials as Topic
Research Design
Respiratory Tract Infections
/ drug therapy
Systematic Reviews as Topic
Time-to-Treatment
general medicine
health economics
respiratory medicine
statistics and research methods
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
21 01 2019
21 01 2019
Historique:
entrez:
24
1
2019
pubmed:
24
1
2019
medline:
20
2
2020
Statut:
epublish
Résumé
Delayed prescribing can be a useful strategy to reduce antibiotic prescribing, but it is not clear for whom delayed prescribing might be effective. This protocol outlines an individual patient data (IPD) meta-analysis of randomised controlled trials (RCTs) and observational cohort studies to explore the overall effect of delayed prescribing and identify key patient characteristics that are associated with efficacy of delayed prescribing. A systematic search of the databases Cochrane Central Register of Controlled Trials, Ovid MEDLINE, Ovid Embase, EBSCO CINAHL Plus and Web of Science was conducted to identify relevant studies from inception to October 2017. Outcomes of interest include duration of illness, severity of illness, complication, reconsultation and patient satisfaction. Study authors of eligible papers will be contacted and invited to contribute raw IPD data. IPD data will be checked against published data, harmonised and aggregated to create one large IPD database. Multilevel regression will be performed to explore interaction effects between treatment allocation and patient characteristics. The economic evaluation will be conducted based on IPD from the combined trial and observational studies to estimate the differences in costs and effectiveness for delayed prescribing compared with normal practice. A decision model will be developed to assess potential savings and cost-effectiveness in terms of reduced antibiotic usage of delayed prescribing and quality-adjusted life years. Ethical approval was obtained from the University of Southampton Faculty of Medicine Research Ethics Committee (Reference number: 30068). Findings of this study will be published in peer-reviewed academic journals as well as General Practice trade journals and will be presented at national and international conferences. The results will have important public health implications, shaping the way in which antibiotics are prescribed in the future and to whom delayed prescriptions are issued. CRD42018079400.
Identifiants
pubmed: 30670532
pii: bmjopen-2018-026925
doi: 10.1136/bmjopen-2018-026925
pmc: PMC6347865
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e026925Subventions
Organisme : Department of Health
ID : CDF-2009-02-10
Pays : United Kingdom
Organisme : Department of Health
ID : PB-PG-0416-20005
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
BMJ. 2013 Mar 11;346:f1493
pubmed: 23479660
BMJ. 2005 Aug 6;331(7512):301-2
pubmed: 16081428
BMJ. 2013 Oct 10;347:f5806
pubmed: 24114306
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Cochrane Database Syst Rev. 2013 Jun 04;(6):CD000247
pubmed: 23733381
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004417
pubmed: 23633320
Syst Rev. 2015 Jul 23;4:98
pubmed: 26202162
Lancet Infect Dis. 2014 Mar;14(3):213-9
pubmed: 24440616
Cochrane Database Syst Rev. 2016 Sep 06;9:MR000007
pubmed: 27595791
BMJ Open. 2016 Nov 18;6(11):e011882
pubmed: 27864242
BMJ. 2010 Feb 05;340:c221
pubmed: 20139215
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Stat Med. 1998 Oct 15;17(19):2265-81
pubmed: 9802183
Br J Gen Pract. 2011 Sep;61(590):e579-89
pubmed: 22152745
BMJ Open Respir Res. 2015 May 06;2(1):e000086
pubmed: 25973210
PLoS One. 2012;7(10):e46042
pubmed: 23056232
Br J Gen Pract. 2016 Sep;66(650):e633-9
pubmed: 27402969
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Cochrane Database Syst Rev. 2013 Nov 05;(11):CD000023
pubmed: 24190439
J Clin Epidemiol. 2002 Jan;55(1):86-94
pubmed: 11781126
Cochrane Database Syst Rev. 2017 Sep 07;9:CD004417
pubmed: 28881007
BMJ. 2010 May 18;340:c2096
pubmed: 20483949
J Clin Epidemiol. 2007 May;60(5):431-9
pubmed: 17419953
Stat Med. 2002 Feb 15;21(3):371-87
pubmed: 11813224
Ann Fam Med. 2016 Jul;14(4):325-36
pubmed: 27401420
Lancet Respir Med. 2016 Nov;4(11):902-910
pubmed: 27594440